These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3263193)

  • 1. Regulation of hybridoma B-cell proliferation by immunoglobulin-binding factor.
    Teillaud JL; Mathiot C; Amigorena S; Brunati S; Moncuit J; Fridman WH
    Cancer Detect Prev; 1988; 12(1-6):115-23. PubMed ID: 3263193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory effects of IgG-BF on hybridoma B cells. molecular characterization of variant cell lines.
    Brunati S; Miossec C; Mathiot C; Moncuit J; Amigorena S; Teillaud JL; Fridman WH
    Mol Immunol; 1988 Nov; 25(11):1133-42. PubMed ID: 2975759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro inhibition of tumor B cell growth by IgG-BF-producing Fc gamma RII+ T cell hybridoma and by immunoglobulin G-binding factors.
    Mathiot C; Amigorena S; Moncuit J; Sautès C; Fridman WH; Teillaud JL
    Immunol Res; 1992; 11(3-4):296-304. PubMed ID: 1287123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of IgG production by suppressor Fc gamma RII+ T hybridomas.
    Brunati S; Moncuit J; Fridman WH; Teillaud JL
    Eur J Immunol; 1990 Jan; 20(1):55-61. PubMed ID: 2137783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin G-binding factors (IgG-BF) inhibit IgG secretion by, as well as proliferation of, hybridoma B cells.
    Teillaud JL; Amigorena S; Moncuit J; Sautès C; Fridman WH
    Immunol Lett; 1987 Nov; 16(2):139-44. PubMed ID: 3501404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of lymphokines produced by human T-T hybridomas on the proliferation of normal and neoplastic B lymphocytes].
    Gambatesa V
    Medicina (Firenze); 1989; 9(2):184-7. PubMed ID: 2811645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCGFII activity on activated B cells of a purified murine T cell-replacing factor (TRF) from a T cell hybridoma (B151K12).
    Harada N; Kikuchi Y; Tominaga A; Takaki S; Takatsu K
    J Immunol; 1985 Jun; 134(6):3944-51. PubMed ID: 3872907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgD-receptor-positive human T lymphocytes. II. Identification and partial characterization of human IgD-binding factor.
    Tamma SM; Coico RF
    J Immunol; 1992 Apr; 148(7):2050-7. PubMed ID: 1545118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors controlling immunoglobulin production and B cell proliferation.
    Fridman WH
    Bull Cancer; 1991; 78(2):195-201. PubMed ID: 2036490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A "lymphokine-like" soluble product that induces proliferation and maturation of B cells appears in the serum-free supernatant of a T cell hybridoma as a consequence of mycoplasmal contamination.
    Proust JJ; Buchholz MA; Nordin AA
    J Immunol; 1985 Jan; 134(1):390-6. PubMed ID: 3871110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional studies on B cell hybridomas with B cell surface antigens. IV. Direct effects of cytochalasin B on differentiation.
    Hamano T; Asofsky R
    J Immunol; 1984 Jan; 132(1):122-8. PubMed ID: 6418794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A sensitive method for testing the effect of immunoglobulin binding factor on Ig secretion by hybridoma B cells.
    Amigorena S; Moncuit J; Fridman WH; Teillaud JL
    J Immunol Methods; 1987 Feb; 97(1):57-64. PubMed ID: 3546505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine IgA binding factors (IgA-BF) suppressing IgA production: characterization and target specificity of IgA-BF.
    Noro N; Adachi M; Yasuda K; Masuda T; Yodoi J
    J Immunol; 1986 Apr; 136(8):2910-6. PubMed ID: 3514749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A serum independent medium effective in all aspects of hybridoma technology and immunological applications.
    Baker P; Knoblock K; Noll L; Wyatt D; Lydersen B
    Dev Biol Stand; 1985; 60():63-72. PubMed ID: 3876250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the macrophage-derived hybridoma growth factor in the in vitro and in vivo proliferation of newly formed B cell hybridomas.
    Bazin R; Lemieux R
    J Immunol; 1987 Aug; 139(3):780-7. PubMed ID: 3496390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine IgA binding factors produced by Fc alpha R(+) T cells: role of Fc gamma R(+) cells for the induction of Fc alpha R and formation of IgA-binding factor in Con A-activated cells.
    Adachi M; Yodoi J; Noro N; Masuda T; Uchino H
    J Immunol; 1984 Jul; 133(1):65-71. PubMed ID: 6233376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cell-specific immunoregulatory factors: development of bioassays for growth and differentiation-promoting activities.
    Altman A
    Lymphokine Res; 1982; 1(3):69-72. PubMed ID: 6985402
    [No Abstract]   [Full Text] [Related]  

  • 19. FcR epsilon+ lymphocytes and regulation of the IgE antibody system. IV. Delineation of target cells and mechanisms of action of SFA and EFA in inhibiting in vitro induction of FcR epsilon expression.
    Marcelletti JF; Katz DH
    J Immunol; 1984 Dec; 133(6):2845-51. PubMed ID: 6238087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferation of hybridoma cells in low-serum medium.
    Sávoly SB; Kovár J; Rossow N
    Acta Histochem Suppl; 1990; 39():125-9. PubMed ID: 2080256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.